Relapsed AML
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia (NCT05226468) | New Epsilon Innovation Limited | 2022-04-25 |
| Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation (NCT03560908) | Institute of Hematology & Blood Diseases Hospital, China | 2018-07-01 |
| Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia (NCT03516760) | AvenCell Europe GmbH | 2018-04-11 |
| Phase 1 Study of Quizartinib (NCT02675478) | Daiichi Sankyo Co., Ltd. | 2016-02-01 |
Track Relapsed AML automatically
Every clearance here is in the API, with alerts when new ones post.